Professeur en thérapeutique, Université de Rennes 1 - Université de Rennes
Hallucinogens approved for treating psychiatric disorders: what does the science say?
Dec 28, 2024 07:16 am UTC| Insights & Views Health
Once sidelined in the 1970s, psychedelic substances ranging from esketamine (a ketamine derivative) and psilocybin (the active ingredient in hallucinogenic mushrooms) to MDMA are being reintroduced as potential therapies...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update